155 related articles for article (PubMed ID: 23196639)
1. Risk score for the prediction of contrast-induced nephropathy in elderly patients undergoing percutaneous coronary intervention.
Fu N; Li X; Yang S; Chen Y; Li Q; Jin D; Cong H
Angiology; 2013 Apr; 64(3):188-94. PubMed ID: 23196639
[TBL] [Abstract][Full Text] [Related]
2. [Risk factors and scoring system in the prediction of contrast induced nephropathy in patients undergoing percutaneous coronary intervention].
Fu NK; Yang SC; Chen YL; Xu J; Li Q; Li XM; Liu YY; Liu XG; Cong HL
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):551-4. PubMed ID: 22490160
[TBL] [Abstract][Full Text] [Related]
3. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.
Wang XC; Fu XH; Wang YB; Jia XW; Wu WL; Gu XS; Zhang J; Su JL; Hao GZ; Jiang YF; Fan WZ; Li SQ
Chin Med J (Engl); 2011 Mar; 124(6):892-6. PubMed ID: 21518598
[TBL] [Abstract][Full Text] [Related]
4. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
[TBL] [Abstract][Full Text] [Related]
6. The impact of iso-osmolar contrast use in emergent percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Kanei Y; Ayabe K; Ratcliffe J; Vales L; Nakra N; Friedman P; Fox J
J Invasive Cardiol; 2011 Nov; 23(11):448-50. PubMed ID: 22045075
[TBL] [Abstract][Full Text] [Related]
7. Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions.
Chong E; Poh KK; Liang S; Soon CY; Tan HC
J Interv Cardiol; 2010 Oct; 23(5):451-9. PubMed ID: 20796168
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of anisodamine on prevention of contrast induced nephropathy in patients with acute coronary syndrome.
Wang YB; Fu XH; Gu XS; Wang XC; Zhao YJ; Hao GZ; Jiang YF; Fan WZ; Wu WL; Li SQ; Xue L
Chin Med J (Engl); 2012 Mar; 125(6):1063-7. PubMed ID: 22613532
[TBL] [Abstract][Full Text] [Related]
9. A simple preprocedural score for risk of contrast-induced acute kidney injury after percutaneous coronary intervention.
Chen YL; Fu NK; Xu J; Yang SC; Li S; Liu YY; Cong HL
Catheter Cardiovasc Interv; 2014 Jan; 83(1):E8-16. PubMed ID: 23907993
[TBL] [Abstract][Full Text] [Related]
10. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
Nyman U; Björk J; Aspelin P; Marenzi G
Acta Radiol; 2008 Jul; 49(6):658-67. PubMed ID: 18568558
[TBL] [Abstract][Full Text] [Related]
11. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification.
Bartholomew BA; Harjai KJ; Dukkipati S; Boura JA; Yerkey MW; Glazier S; Grines CL; O'Neill WW
Am J Cardiol; 2004 Jun; 93(12):1515-9. PubMed ID: 15194023
[TBL] [Abstract][Full Text] [Related]
12. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
Worasuwannarak S; Pornratanarangsi S
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
[TBL] [Abstract][Full Text] [Related]
13. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.
Marenzi G; Lauri G; Assanelli E; Campodonico J; De Metrio M; Marana I; Grazi M; Veglia F; Bartorelli AL
J Am Coll Cardiol; 2004 Nov; 44(9):1780-5. PubMed ID: 15519007
[TBL] [Abstract][Full Text] [Related]
14. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention.
Kandula P; Shah R; Singh N; Markwell SJ; Bhensdadia N; Navaneethan SD
Nephrology (Carlton); 2010 Mar; 15(2):165-70. PubMed ID: 20470274
[TBL] [Abstract][Full Text] [Related]
15. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.
Dangas G; Iakovou I; Nikolsky E; Aymong ED; Mintz GS; Kipshidze NN; Lansky AJ; Moussa I; Stone GW; Moses JW; Leon MB; Mehran R
Am J Cardiol; 2005 Jan; 95(1):13-9. PubMed ID: 15619387
[TBL] [Abstract][Full Text] [Related]
16. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment.
Pyxaras SA; Sinagra G; Mangiacapra F; Perkan A; Di Serafino L; Vitrella G; Rakar S; De Vroey F; Santangelo S; Salvi A; Toth G; Bartunek J; De Bruyne B; Wijns W; Barbato E
Am J Cardiol; 2013 Mar; 111(5):684-8. PubMed ID: 23261003
[TBL] [Abstract][Full Text] [Related]
17. Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention.
Tan N; Liu Y; Zhou YL; He PC; Yang JQ; Luo JF; Chen JY
Catheter Cardiovasc Interv; 2012 Jan; 79(1):70-5. PubMed ID: 21990069
[TBL] [Abstract][Full Text] [Related]
18. Risk score for contrast induced nephropathy following percutaneous coronary intervention.
Ghani AA; Tohamy KY
Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):240-5. PubMed ID: 19237811
[TBL] [Abstract][Full Text] [Related]
19. Female gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation myocardial infarction.
Lucreziotti S; Centola M; Salerno-Uriarte D; Ponticelli G; Battezzati PM; Castini D; Sponzilli C; Lombardi F
Int J Cardiol; 2014 Jun; 174(1):37-42. PubMed ID: 24698233
[TBL] [Abstract][Full Text] [Related]
20. Diabetic patients with normal baseline renal function are at increased risk of developing contrast-induced nephropathy post-percutaneous coronary intervention.
Chong E; Poh KK; Shen L; Chai P; Tan HC
Singapore Med J; 2009 Mar; 50(3):250-4. PubMed ID: 19352566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]